WIKSTROM; Hakan

Patent Applications and Registrations

Patent applications and USPTO patent grants for WIKSTROM; Hakan.The latest application filed is for "pharmaceutical compositions comprising (2s)-n-{(1s)-1-cyano-2-[4-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-5-yl- )phenyl]ethyl}-1,4-oxazepane-2-carboxamide".

Company Profile

0.5.12

WIKSTROM; Hakan - MOLNDAL SE
Wikstrom; HaKan - Hamburgsund SE
Wikstrom; Hakan - Groningen NL
Wikstrom; Hakan - WN Groningen NL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
PHARMACEUTICAL COMPOSITIONS COMPRISING (2S)-N-{(1S)-1-CYANO-2-[4-(3-METHYL-2-OXO-2,3-DIHYDRO-1,3-BENZOXAZOL-5-yl- )PHENYL]ETHYL}-1,4-OXAZEPANE-2-CARBOXAMIDE App 20210369732 - WIKSTROM; Hakan ; et al.	2021-12-02
Catecholamine Derivatives And Prodrugs Thereof App 20120196889 - Bang-Andersen; Benny ; et al.	2012-08-02
Treatment Of Dyskinesia Related Disorders App 20120108624 - Wikstrom; Hakan ; et al.	2012-05-03
Methods Of Administering (4ar,10ar)-1-n-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo [g] Quinoline-6,7-diol And Related Compounds Across The Oral Mucosa, The Nasal Mucosa Or The Skin And Pharmaceutical Compositions Thereof App 20120077836 - Wikstrom; Hakan ; et al.	2012-03-29
Pharmaceutical Formulation For The Efficient Administration Apomorphine, 6ar-(-)-n-propyl-norapomorphine And Their Derivatives And Pro-drugs Thereof App 20080145417 - Wikstrom; Hakan ; et al.	2008-06-19
New Aporphine Esters And Their Use In Therapy App 20080119504 - WIKSTROM; Hakan ; et al.	2008-05-22
Aporphine esters and their use in therapy Grant 7,332,503 - Wikstrom , et al. February 19, 2	2008-02-19
Aporphine esters and their use in therapy Grant 7,238,705 - Wikstrom , et al. July 3, 2	2007-07-03
Mono-ester and asymmetrically substatuted di-ester pro-drugs of dopamide D1 receptor agonists Grant 7,220,754 - Dijkstra , et al. May 22, 2	2007-05-22
Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use Grant 6,998,405 - Wikstrom , et al. February 14, 2	2006-02-14
Aporphine esters and their use in therapy App 20050143408 - Wikstrom, Hakan ; et al.	2005-06-30
Mono-ester and asymmetrically substatuted di-ester pro-drugs of dopamide d1 receptor agonists App 20050096469 - Dijkstra, Durk ; et al.	2005-05-05
Pharmaceutical formulation for the efficient administration of apomorphine, 6ar-(-)-n-propyl-norapomorphine and their derivatives and pro-drugs thereof App 20040220205 - Wikstrom, Hakan ; et al.	2004-11-04
Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use App 20040138281 - Wikstrom, Hakan ; et al.	2004-07-15
Aporphine esters and their use in therapy App 20040018956 - Wikstrom, Hakan ; et al.	2004-01-29
Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use App 20030087948 - Wikstrom, Hakan ; et al.	2003-05-08
Iodinated x-ray contrast media Grant 6,310,243 - Almen , et al. October 30, 2	2001-10-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.